Literature DB >> 24696259

Evaluation of the seventh AJCC TNM staging system for gastric cancer: a meta-analysis of cohort studies.

Jizhun Zhang1, Yangbing Zhou, Kewei Jiang, Zhanlong Shen, Yingjiang Ye, Shan Wang.   

Abstract

The AJCC seventh edition TNM classification for gastric cancer was released in 2010 and included major revision. Large-volume gastric cancer centers have evaluated the prognostic significance of the new system and obtained paradoxical results. The authors performed a meta-analysis of these studies to evaluate the new classification. Fifteen eligible studies with 38,972 patients were included in the analysis. Hazard ratios (HRs) and associated 95 % confidence intervals were extracted from identified studies. The primary outcome was overall survival. The HRs for the seventh edition T classification and N classification were found to increase steadily and reasonably. The cumulative survival rates of the seventh edition subgroups of T classifications demonstrated obvious differences; meanwhile, the differences between subgroups of N classifications including N3a and N3b categories were also significant. The 5-year survival rates according to the seventh edition TNM staging system were 94.71 % (stage IA), 88.72 % (stage IB), 80.45 % (stage IIA), 67.24 % (stage IIB), 53.68 % (stage IIIA), 37.56 % (stage IIIB), and 21.26 % (stage IIIC), respectively. The results of this study indicate that the seventh edition of the TNM classification was considered valid, although further evaluation was needed for N3a and N3b categories.

Entities:  

Mesh:

Year:  2014        PMID: 24696259     DOI: 10.1007/s13277-014-1848-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  38 in total

Review 1.  TNM and Japanese staging systems for gastric cancer: how do they coexist?

Authors:  Mazin E Sayegh; Takeshi Sano; Simon Dexter; Hitoshi Katai; Takeo Fukagawa; Mitsuru Sasako
Journal:  Gastric Cancer       Date:  2004       Impact factor: 7.370

2.  Validation of the seventh edition of the American Joint Committee on Cancer TNM staging system for gastric cancer.

Authors:  Hun Jung; Han Hong Lee; Kyo Young Song; Hae Myung Jeon; Cho Hyun Park
Journal:  Cancer       Date:  2011-01-11       Impact factor: 6.860

3.  A note on quantifying follow-up in studies of failure time.

Authors:  M Schemper; T L Smith
Journal:  Control Clin Trials       Date:  1996-08

4.  [The Comparison between 6th and 7th International Union Against Cancer/American Joint Committee on Cancer Classification for Survival Prognosis of Gastric Cancer].

Authors:  Su Sun Kim; Bo Youn Choi; Seung In Seo; Min Young Jung; Hyuk Su Choi; Sung Min Ahn; Won Hyuk Choi; Hyoung Su Kim; Kyung Ho Kim; Myoung Kuk Jang; Jin Heon Lee; Hak Yang Kim; Woon Geon Shin
Journal:  Korean J Gastroenterol       Date:  2011-11-25

5.  Evaluation of the seventh American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classification.

Authors:  Hye Seong Ahn; Hyuk-Joon Lee; Seokyung Hahn; Woo-Ho Kim; Kuhn Uk Lee; Takeshi Sano; Stephen B Edge; Han-Kwang Yang
Journal:  Cancer       Date:  2010-08-24       Impact factor: 6.860

6.  Seventh edition (2010) of the AJCC/UICC staging system for gastric adenocarcinoma: is there room for improvement?

Authors:  Manali I Patel; Kim F Rhoads; Yifei Ma; James M Ford; Brendan C Visser; Pamela L Kunz; George A Fisher; Daniel T Chang; Albert Koong; Jeffrey A Norton; George A Poultsides
Journal:  Ann Surg Oncol       Date:  2012-11-13       Impact factor: 5.344

7.  Tumor-ratio-metastasis staging system as an alternative to the 7th edition UICC TNM system in gastric cancer after D2 resection--results of a single-institution study of 1343 Chinese patients.

Authors:  W Wang; D Z Xu; Y F Li; Y X Guan; X W Sun; Y B Chen; R Kesari; C Y Huang; W Li; Y Q Zhan; Z W Zhou
Journal:  Ann Oncol       Date:  2011-02-10       Impact factor: 32.976

8.  Validation of the updated 7th edition AJCC TNM staging criteria for gastric adenocarcinoma.

Authors:  Lee J McGhan; Barbara A Pockaj; Richard J Gray; Sanjay P Bagaria; Nabil Wasif
Journal:  J Gastrointest Surg       Date:  2011-10-05       Impact factor: 3.452

9.  The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients.

Authors:  Alberto Marchet; Simone Mocellin; Alessandro Ambrosi; Paolo Morgagni; Domenico Garcea; Daniele Marrelli; Franco Roviello; Giovanni de Manzoni; Annamaria Minicozzi; Giovanni Natalini; Francesco De Santis; Luca Baiocchi; Arianna Coniglio; Donato Nitti
Journal:  Ann Surg       Date:  2007-04       Impact factor: 12.969

10.  Practical methods for incorporating summary time-to-event data into meta-analysis.

Authors:  Jayne F Tierney; Lesley A Stewart; Davina Ghersi; Sarah Burdett; Matthew R Sydes
Journal:  Trials       Date:  2007-06-07       Impact factor: 2.279

View more
  11 in total

1.  Clinical characteristics of hepatoduodenal lymph node metastasis in gastric cancer.

Authors:  Taisuke Imamura; Shuhei Komatsu; Daisuke Ichikawa; Toshiyuki Kosuga; Kazuma Okamoto; Hirotaka Konishi; Atsushi Shiozaki; Hitoshi Fujiwara; Eigo Otsuji
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

2.  The 7th AJCC/UICC TNM staging system may be not suitable in predicting prognosis of synchronous multiple gastric carcinoma patients with D2 gastrectomy.

Authors:  Xiaolong Tang; Zhongmin Lan; Yingtai Chen; Jianwei Zhang; Xu Che; Chengfeng Wang
Journal:  Tumour Biol       Date:  2015-01-08

3.  Evaluating TNM stage prognostic ability in a population-based cohort of gastric adenocarcinoma patients in a low-incidence country.

Authors:  Alyson L Mahar; Brandon Zagorski; Daniel Kagedan; Matthew Dixon; Abraham El-Sedfy; Jovanka Vasilevska-Ristovska; Daniela Cortinovis; Corwyn Rowsell; Calvin Law; Lucy Helyer; Lawrence Paszat; Natalie Coburn
Journal:  Can J Public Health       Date:  2018-08-08

4.  Validation of the 7th AJCC/UICC staging system for gastric cancer and a proposal for a new TNM system based on a prognostic score: a retrospective multicenter study.

Authors:  Oh Kyoung Kwon; Se Won Kim; Hyun-Dong Chae; Seung Wan Ryu; Ho Young Chung; Sang Woon Kim; Won Kee Lee; Wansik Yu
Journal:  Ann Surg Treat Res       Date:  2016-11-25       Impact factor: 1.859

5.  Factors associated with early recurrence after curative surgery for gastric cancer.

Authors:  Wei-Ming Kang; Qing-Bin Meng; Jian-Chun Yu; Zhi-Qiang Ma; Zhi-Tian Li
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

6.  The prognostic significance of lymphovascular invasion in patients with resectable gastric cancer: a large retrospective study from Southern China.

Authors:  Peng Li; Hao-Qiang He; Chong-Mei Zhu; Yi-Hong Ling; Wan-Ming Hu; Xin-Ke Zhang; Rong-Zhen Luo; Jing-Ping Yun; Dan Xie; Yuan-Fang Li; Mu-Yan Cai
Journal:  BMC Cancer       Date:  2015-05-07       Impact factor: 4.430

7.  FGF7/FGFR2 signal promotes invasion and migration in human gastric cancer through upregulation of thrombospondin-1.

Authors:  Tingting Huang; Lei Wang; Dian Liu; Piao Li; Huihua Xiong; Liang Zhuang; Li Sun; Xianglin Yuan; Hong Qiu
Journal:  Int J Oncol       Date:  2017-03-22       Impact factor: 5.650

8.  Prognostic Discrepancy of the 6th and 7th UICC N Classification for Lymph Node Staging in Gastric Cancer Patients after Curative Resection.

Authors:  Sung Jin Oh; Byoung Jo Suh; Jong Kwon Park; Sung Don Oh; Hang Jong Yu
Journal:  Case Rep Oncol       Date:  2017-01-17

9.  Prognostic Value of microRNA Signature in Patients with Gastric Cancers.

Authors:  Hai-Ting Liu; Ya-Wen Wang; Ai-Yan Xing; Duan-Bo Shi; Hui- Zhang; Xiang-Yu Guo; Jing- Xu; Peng Gao
Journal:  Sci Rep       Date:  2017-02-16       Impact factor: 4.379

10.  D-Dimer Can Serve as a Prognostic and Predictive Biomarker for Metastatic Gastric Cancer Treated by Chemotherapy.

Authors:  Se-Il Go; Min Jeong Lee; Won Sup Lee; Hye Jung Choi; Un Seok Lee; Rock Bum Kim; Myoung Hee Kang; Hoon-Gu Kim; Gyeong-Won Lee; Jung Hun Kang; Jeong-Hee Lee; Sun Joo Kim
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.